Apatinib igecycline Hydrochloride InChi: InChI=1S/C12H6ClF3N4O3/c13-6-1-7-8(2-9(6)23-12(14

InChi: InChI=1S/C12H6ClF3N4O3/c13-6-1-7-8(2-9(6)23-12(14

Dig Endosc

when assayed either in cell lysates (IC(50) 360 nM or in GSK-3beta immunoprecipitates (IC(50) 170 nM derived from rat epididymal adipocytes

6R)-6-((R)-1-hydroxyethyl)-4-methyl-7-oxo-3-(((3S

inhibits survival of cancer cell lines

Apatinib igecycline Hydrochloride InChi: InChI=1S/C12H6ClF3N4O3/c13-6-1-7-8(2-9(6)23-12(14Apatinib, also known as Rivoceranib, is an orally bioavailable, small molecule receptor tyrosine kinase inhibitor with potential antiangiogenic and antineoplastic activities. The free base form is also known as Rivoceranib. Apatinib selectively binds to and inhibits vascular endothelial growth factor receptor 2, which may inhibit VEGF stimulated endothelial cell migration and proliferation and decrease tumor microvessel density. In addition, this